Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Showing 1 to 6 of 6 results for ursodeoxycholic acid

  1. Obeticholic acid for treating primary biliary cholangitis (TA443)

    Evidence-based recommendations on obeticholic acid (Ocaliva) for treating primary biliary cholangitis in adults.

  2. Elafibranor for treating primary biliary cholangitis [ID6331]

    In development [GID-TA11378] Expected publication date: TBC

  3. Cystic fibrosis: diagnosis and management (NG78)

    This guideline covers diagnosing and managing cystic fibrosis. It specifies how to monitor the condition and manage the symptoms to improve quality of life. There are also detailed recommendations on treating the most common infections in people with cystic fibrosis.

  4. Liver disease:- Should all children with meconium ileus receive ursodeoxycholic acid from diagnosis?

    Liver disease:- Should all children with meconium ileus receive ursodeoxycholic acid from diagnosis? Any explanatory notes(if...

  5. Odevixibat for treating progressive familial intrahepatic cholestasis (HST17)

    Evidence-based recommendations on odevixibat (Bylvay) for treating progressive familial intrahepatic cholestasis in people 6 months and older.

  6. Research recommendations

    CG155/2 | What is the clinical and cost effectiveness of omega-3 fatty acids in the treatment of children and young people considered...